2014 Board and Advisor

Dr. Michelle Chen, President Dr. Chen is a biotech entrepreneur & executive with extensive experience in biopharma, diagnostics and life sciences. She has a track record of successful leadership roles in business development, marketing and R&D. Most recently she was a business development executive at Hoffmann-La Roche responsible for global oncology licensing, collaborations and M&A. Prior to this role, she was involved in the personalized medicine effort for Roche. Dr. Chen started her biotech career in early drug discovery& development at Scios and later Abgenix as a group leader working on the assay development of antibody drugs. She then went on to gain commercial experience at Agilent Technologies and Applied Biosystems respectively. Dr. Chen received a PhD in Biochemistry from the University of Washington, followed by the post-doctoral work at UCSF and bioinformatics training at Stanford University. She has been a CBA board member, advisor and volunteer in the last five years and a FAST program advisor for BayBio dedicated to help biotech start-ups grow and succeed.

Dr. Patty Kiang, Vice-President Dr. Kiang is a Biopharmaceutical Consultant on Quality Systems and Delivery Devices. She was Director of Business Development for Catalent Pharmaceutical Solutions’west coast operation, prior to Catalent, she was Head of Device Development for Genentech Inc. in South San Francisco, CA. She was responsible for the development of various injection devices and Extractable / Leachable program for evaluation of primary container/closure systems. Prior to joining Genentech, she was Director, Sterile Injectable Delivery Device and Packaging Support for Schering Plough, in Kenilworth, NJ. She also had various positions at West Pharmaceutical Services in Exton, PA, as Director of Technology Development, and Director of Quality Control and Method development. She is a member of the faculty of the PDA’s Training and Research Institute, where she teaches courses on Prefilled Syringe& injection devices, Extractables / leachables, and Parenteral Packaging; she served as a member of USP’s Expert Committee on Drug Packaging, Storage and Distribution. She was the chairperson for PDA Gamma Radiation Sterilization of Polymeric Materials Committee. She is an expert in the area of drug and container / closure interactions and compatibility issues. She was the President of Chinese Bioscience Association in 2011. She holds five patents in the field of polymeric surface coatings and received a Ph.D. in Analytical Chemistry from Villanova University and an MBA from Pennsylvania State University.

Dr. Lin Sun-Hoffman, Advisor  Dr. Sun-Hoffman is a licensed patent attorney and advises on issues related to intellectual property and technology transfer matters. She also consults on biotechnology and pharmaceutical business-related matters. She helps businesses expand into China through providing strategic and practical advice on issues as diverse as government relations, research and/or business partnerships between Chinese and American companies, intellectual property protection and drug regulatory matters. She previously worked for Life Technologies/ABI, BIO, Celera Genomics, US Patent and Trademark Office and National Institutes of Health.  She is the former president of Chinese Biopharmaceutical Association based in Washington DC, currently serves on board of US China Green Energy Council, a member of Bayhelix.  Dr. Sun-Hoffman has a PhD in Biochemistry/Cell and Molecular Biology. She was the president of CBA 2013.

Dr. Katherine Wang, Treasurer Katherine Wang got her B.S. degree in Optics from Shandong University, and Ph.D. in Physics from Syracuse University. She worked as research scientist in Neurodegenerative Diseases Center of University of Virginia. She has years of Hands-on experiences in optical engineering, DNA sequencing, protein purification, drug-protein interactions and cell culture. Professionally trained as physicist, later she discovered that her real interest is in clinical data analysis. She is currently doing statistical programming after she led clinical programming projects at Gilead Sciences for around two years. Previously she worked as certified advanced SAS programmer and data manager as well in Clinovo. Katherine’s diligent work and enthusiasm have been well recognized. She enjoys reading, writing and Scottish Country Dancing.

Ms. Cindy Liu, Publications  Cindy received her M.S. in Biochemistry from University of Maryland. She has over 15 years of working experience in academic, biotech and biopharmaceutical industries, focusing on protein chemistry, assay development, and quality system. Currently she is a supervisor of quality control-bioanalytics at Solstice Neurosciences (a US WorldMeds comapny). Prior to Solstice, she worked at SynPep, Universityof California, Bionetics, and University of Maryland. Cindy has been a CBA board member and volunteer in the past few years. For leisure, she likes photography, gardening and music.

Mr. Frank Lin, Taiwan Liaison Mr. Frank Lin is the Regional Sales Marketing Director at Specialdeals.com, a VC funded startup a deal-of-the-day website that features discounted gift certificates usable at local or national companies. Frank Lin is the Regional Marketing Director in US and General Manager in Asia Pacific at Matchbin, Inc, a Web 2.0 Content Management System (CMS) provider for newspaper/radio station/magazine industry. Prior to that, Mr. Lin was a Sales Operation / Marketing Specialist at VeriSilicon, a Fabless Semiconductor company. Mr. Lin now is the Marketing Manager at GBC (www.gbc.com.tw). Mr. Lin received his B.A. degree in Electrical and Computer Engineering from Purdue University and an MBA from Santa Clara University.

Mr. Andrew Teng, Taiwan Liaison  Currently acting as C.S.O. at Sunwell Scientific Inc. Mr. Teng has more than 16 years of general management experience in the fields of semiconductor and Bio Science. His broad background includes P&L, operational, BD, product development, marketing, IP protection and M&A. He was a Managing Director at Ecos Lab Co. Prior to joining Ecos Lab, Mr. Teng held a senior positions with Encepho Pharmaceutical as V.P. of Business Development. Mr. Teng has extensive international experience having had direct responsibility for business development and strategic planning in Greater China. Mr. Teng has a B.S. degree from San Jose State University.  Currently studying PhD in Industrial Economics at Jinan University, China.

Dr. Patrick Yang, Alliance Dr. Patrick Yang is currently Principal Scientist at Relypsa, Inc.  He has been working in bay area for many years in various pharmaceutical companies in the field of CMC/analytical development.  Dr. Yang obtained his Ph. D. in pharmaceutical sciences from University of the Pacific, USA. He has previously served on CBA board several terms.

Dr. Kai Zheng, Membership Dr. Kai Zheng received his Ph.D. from the Department of Pharmaceutical Chemistry at the University of Kansas. After graduation, he joined Genentech Oceanside site and focused on the protein formulation development at early stages. After working at Oceanside for 4 years, he moved to Genentech SSF site and joined the late stage pharmaceutical development department. He is working on Phase III and commercial formulation development now. When he was in Oceanside, he was a member of SABPA (Sino-American Biomedical and Pharmaceutical Professionals Association) and worked as meeting volunteers.

Dr. Pengguang Wu, E-communication Dr. Wu is interested in healthcare, mobile health, and internet of things. He previously worked at Exelixis in the area of assay development, high throughput screening, compound management, and translational medicine biorepository in oncology. Proior to that, he worked at Tularik in assay development,  screening, and lead optimization in anti-infectives, immunology/inflammation, and oncology. He obtained his BSc in chemistry from Shandong University, China. His PhD was in physical chemistry of nucleic acid/drug complex from the Department of Chemistry, University of Washington, Seattle. He did a postdoc studying DNAs with modified bases in the Departments of Physics and Biophysics at University of Rochester, Rochester, New York. He did another postdoc studying protein folding in the Department of Biology, Johns Hopkins University, Baltimore, MD.

Mark Chen, Secretary
Hui Fang Li, Press relationship
Jing Folsom, Sponsorship
Caesar Ho, Scholarship